Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug #Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate #COVID19 symptoms at a price of Rs 39 per tablet.
STOCK MARKET | BSE | NSE | ||||||
Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug #Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate #COVID19 symptoms at a price of Rs 39 per tablet.
O
P
E
N
Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.
The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.
Quad summit: PM Modi to skip going to Netaji memorial at Renkoji temple again
Sushil Modi poses five questions before Lalu family after CBI raid
Quad summit: PM Modi likely to talk about China in the context of Indo-Pacific
Assam flood: Four more deaths take the toll to 18; 6.8 lakh affected
Bengal Education Minister interrogated for four hours by CBI on appointment of daughter
Azam Khan appears before court in fake birth certificate case of son